These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31671222)

  • 41. Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital.
    Yao H; Jiang F; Hu H; Gao Y; Zhu Z; Zhang H; Wang Y; Guo Y; Liu L; Yuan Y; Zhou L; Wang J; Du B; Qu N; Zhang R; Dong Y; Xu H; Chen F; Jiang H; Liu Y; Zhang L; Tian Z; Liu Q; Zhang C; Pan X; Yang S; Zhao L; Wang W; Liang Z
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):17-24. PubMed ID: 24616044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-invasive prenatal testing of fetal chromosomal aneuploidies: validation and clinical performance of the veracity test.
    Kypri E; Ioannides M; Touvana E; Neophytou I; Mina P; Velissariou V; Vittas S; Santana A; Alexidis F; Tsangaras K; Achilleos A; Patsalis P; Koumbaris G
    Mol Cytogenet; 2019; 12():34. PubMed ID: 31338126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies.
    Hudecova I; Sahota D; Heung MM; Jin Y; Lee WS; Leung TY; Lo YM; Chiu RW
    PLoS One; 2014; 9(2):e88484. PubMed ID: 24586333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical features of abnormal chromosome karyotypes in twin pregnancies complicated with structural abnormalities].
    Zhong SL; Fang Q; Chen BJ; Han ZY; Luo YM; Chen JS; Xie YJ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):649-54. PubMed ID: 22176987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Method to Quantify Cell-Free Fetal DNA Fraction in Maternal Plasma Using Next Generation Sequencing: Its Application in Non-Invasive Prenatal Chromosomal Aneuploidy Detection.
    Xu XP; Gan HY; Li FX; Tian Q; Zhang J; Liang RL; Li M; Yang XX; Wu YS
    PLoS One; 2016; 11(1):e0146997. PubMed ID: 26765738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a novel screening method for fetal aneuploidy using cell-free DNA in maternal plasma.
    Porreco RP; Sekedat M; Bombard A; Garite TJ; Maurel K; Marusiak B; Adair D; Bleich A; Combs CA; Kramer W; Longo S; Nageotte M; Samuel A; Vanderhoeven J; Buis J; Jacobs KB; Stoerker J
    J Med Screen; 2020 Mar; 27(1):1-8. PubMed ID: 31510865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations.
    Skotko BG; Allyse MA; Bajaj K; Best RG; Klugman S; Leach M; Meredith S; Michie M; Stoll K; Gregg AR
    Genet Med; 2019 Oct; 21(10):2285-2292. PubMed ID: 30940924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?
    Reiss RE; Discenza M; Foster J; Dobson L; Wilkins-Haug L
    Prenat Diagn; 2017 May; 37(5):515-520. PubMed ID: 28326560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of non-invasive prenatal testing for trisomies 21 and 18 in twin pregnancies.
    Yang J; Qi Y; Hou Y; Guo F; Peng H; Wang D; Haoxin OY; Wang Y; Huang H; Yin A
    Mol Cytogenet; 2018; 11():47. PubMed ID: 30166996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Novel Graphic-Aided Algorithm (gNIPT) Improves the Accuracy of Noninvasive Prenatal Testing.
    Zhu Q; Wang J; Xu X; Zhou S; Liao Z; Zhang J; Kong L; Liang B; Cheng X
    Biomed Res Int; 2020; 2020():4712657. PubMed ID: 32775425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Preliminary analysis of the cause for the failure of non-invasive prenatal testing using cell-free fetal DNA derived from peripheral maternal blood].
    Zhang B; Shen C; Wang H; Cai Z; Lu B; Zhang X; Yu B; Wang T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):329-333. PubMed ID: 29896725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Level of Free Fetal DNA as Precise Noninvasive Marker for Chromosomal Aneuploidies: First Results from BALTIC Region.
    Serapinas D; Boreikaitė E; Bartkevičiūtė A; Norvilaitė K; Narbekovas A; Bartkevičienė D
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33143018
    [No Abstract]   [Full Text] [Related]  

  • 54. Chromosomal phase improves aneuploidy detection in non-invasive prenatal testing at low fetal DNA fractions.
    Genovese G; Mello CJ; Loh PR; Handsaker RE; Kashin S; Whelan CW; Bayer-Zwirello LA; McCarroll SA
    Sci Rep; 2022 Jul; 12(1):12025. PubMed ID: 35835769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temporal persistence of residual fetal cell-free DNA from a deceased cotwin after selective fetal reduction in dichorionic diamniotic twin pregnancies.
    Chen M; Su F; Wang J; Zhou L; Liu Q; Chai X; Yuan Y; Cen M; Wu Y; Wang Y; Chen F; Zhang Y; Chen D; Gao Y
    Prenat Diagn; 2021 Nov; 41(12):1602-1610. PubMed ID: 33555061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance of semiconductor sequencing platform for non-invasive prenatal genetic screening for fetal aneuploidy: results from a multicenter prospective cohort study in a clinical setting.
    El Khattabi LA; Brun S; Gueguen P; Chatron N; Guichoux E; Schutz S; Nectoux J; Sorlin A; Quere M; Boudjarane J; Tsatsaris V; Mandelbrot L; Schluth-Bolard C; Dupont JM; Rooryck C;
    Ultrasound Obstet Gynecol; 2019 Aug; 54(2):246-254. PubMed ID: 30191619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Setup and Application of Reference Material in Sequencing-Based Noninvasive Prenatal Testing.
    Qu S; Zhang Y; Yang X; Tan Y; Li M; Yang X; Zhou L; Chen D; Chen Y; Yan M; Wang Q; Yu T; Sun N; Jiang H; Su F; Di Y; Lin G; Yuan Y; Chen F; Mu F; Huang J
    Gynecol Obstet Invest; 2021; 86(1-2):123-131. PubMed ID: 33784691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated.
    Lopes JL; Lopes GS; Enninga EAL; Kearney HM; Hoppman NL; Rowsey RA
    Prenat Diagn; 2020 Jun; 40(7):831-837. PubMed ID: 32274800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.